Publication dates

All regions

Ovarian Cancer Industry, August 2014 Market Reports from Top Publishers

You might be interested in: cancer, therapeutics, medical equipment, more »


 
1-20 of about 5 900 reports for Ovarian Cancer

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

HealthLinx Limited (Symbol:HTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • August 2014
  • by Global Data

... And diagnostic products. Its products include cr0014, ovplex, and clear it. Healthlinx's cr014 is an inhibitor of vascular leak; ovplex is a multimarker blood test for ovarian cancer; and clear it is a protein ...

Oncology Research Digest H1 2014

Oncology Research Digest H1 2014

  • $ 350
  • Industry report
  • August 2014
  • by TBRC Business Research

... Areas such as biosimilars, novel immunotherapies, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer, ovarian cancer and drugs such as rituxan, avastin, herceptin, traceva ...

Trends in Therapeutic Partnering

Trends in Therapeutic Partnering

  • $ 3 995
  • Industry report
  • August 2014
  • by Currentpartnering

... Most active transplantation partnering companies22. Obesityobesity partnering in numberstop obesity partnering deals by valuemost active obesity partnering companies23. ovarian cancerovarian ...

Ovarian Cancer Partnering 2009-2014

Ovarian Cancer Partnering 2009-2014

  • $ 995
  • Industry report
  • August 2014
  • by Currentpartnering

... Report contains over 75 links to online copies of actual ovarian cancer deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available ...

 Epithelial Ovarian Cancer-Pipeline Insights, 2014

Epithelial Ovarian Cancer-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under epithelial ovarian cancer. This report provides information ...

 Metastatic Ovarian Cancer-Pipeline Insights, 2014

Metastatic Ovarian Cancer-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

... Across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under metastatic ovarian cancer. This report provides information ...

Ovarian Cancer Drug Pipeline Update 2014

Ovarian Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... There are 8 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 96 drugs. ovarian cancer drug pipeline update lists all drugs and gives you a progress analysis ...

Ovarian Cancer Drug Pathway Analyzer 2014

Ovarian Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

... To your pipeline specifications3. Compare - you can overlay any pathways with each other and do a comparative analysisyou can interactively analyze any ovarian cancer drug ...

AIDS - Related Kaposi%s Sarcoma - Pipeline Review, H2 2014

AIDS - Related Kaposi%s Sarcoma - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

... Of ontak, targretin and panretin 54apr 15, 1999: supplemental nda for alza's doxil in refractory ovarian cancer granted priority review. 54Mar 30, 1999: ligand and fer entered into agreement ...

Epithelial Ovarian Cancer - Pipeline Review, H2 2014

Epithelial Ovarian Cancer - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • July 2014
  • by Global Markets Direct

... ovarian cancer pipeline on the basis of target, moa, route of administration and molecule type- latest news and deals relating related to pipeline productsreasons to buy- provides ...

About 1 200 reports for Ovarian Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Disease State Primer: Ovarian Cancer
  • January 2012
    8 pages
  • Ovarian Cancer  

    Cancer  

  • United States  

    World  

    North America  

View report >

1 Companies for Ovarian Cancer

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.